AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • January 10th, 2023 • Sesen Bio, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 10th, 2023 Company Industry JurisdictionTHIS AMENDED AND RESTATED SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of December 29, 2022 (the “Effective Date”) by and among CARISMA Therapeutics Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Schedule I hereto, severally and not jointly (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 7 hereof.
SUBSCRIPTION AGREEMENTSubscription Agreement • November 22nd, 2022 • Sesen Bio, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionTHIS SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into as of September 20, 2022 (the “Effective Date”) by and among CARISMA Therapeutics Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on the signature pages hereto, severally and not jointly (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 7 hereof.